The Role of Vitamin D in Diabetes and Cardiovascular Disease: An Updated Review of the Literature

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Papandreou, Dimitrios ^a   Hamid, Zujaja Tul Noor ^a  

^a ZAYED UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; VITAMIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR INFLAMMATION; DIABETES MELLITUS; DISEASE COURSE; GESTATION PERIOD; HEREDITY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR DISEASES; CLINICAL TRIAL (TOPIC); GENETICS; METABOLISM;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; HUMANS; VITAMIN D; VITAMINS;

EID: 84947968599     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/580474     Document Type: Review

References (124)

1. A. C. Ross, C. L. Taylor, A. L. Yaktine, and H. B. Del Valle, Dietary Reference Intakes for Calcium and Vitamin D, National Academies Press, Washington, DC, USA, 2011.
2. M. F. Holick, "Vitamin D status: measurement, interpretation, and clinical application," Annals of Epidemiology, vol. 19, no. 2, pp. 73-78, 2009.
3. S. J. Ball, A. Haynes, P. Jacoby et al., "Spatial and temporal variation in type 1 diabetes incidence inWestern Australia from 1991 to 2010: increased risk at higher latitudes and over time," Health and Place, vol. 28, pp. 194-204, 2014.
4. D. Papandreou, P. Malindretos, Z. Karabouta, and I. Rousso, "Possible health implications and low vitamin D status during childhood and adolescence: an updated mini review," International Journal of Endocrinology, vol. 2010, Article ID 472173, 7 pages, 2010.
5. H. K. Joh, C. S. Lim, and B. Cho, "Lifestyle and dietary factors associated with serum 25-hydroxyvitamin D levels in Korean young adults," Journal of Korean Medical Science, vol. 30, no. 8, pp. 1110-1120, 2015.
6. T. J. Wang, F. Zhang, J. B. Richards et al., "Common genetic determinants of vitamin D insufficiency: a genome-wide association study," The Lancet, vol. 376, no. 9736, pp. 180-188, 2010.
7. S. Christakos, M. Hewison, D. G. Gardner et al., "Vitamin D: beyond bone," Annals of the New York Academy of Sciences, vol. 1287, no. 1, pp. 45-58, 2013.
8. S. Mohammadian, N. Fatahi, H. Zaeri, andM. A. Vakili, "Effect of vitamin D3 supplement in glycemic control of pediatricswith type 1 diabetes mellitus and vitamin D deficiency," Journal of Clinical and Diagnostic Research, vol. 9, no. 3, pp. SC05-SC07, 2015.
9. C. Wang, "Role of vitamin D in cardiometabolic diseases," Journal of Diabetes Research, vol. 2013, Article ID 243934, 10 pages, 2013.
10. L. Schneider, P. L. Lutsey, E. Selvin et al., "Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study," European Journal of Neurology, vol. 22, no. 8, pp. 1220-1227, 2015.
11. Y. Hao, X. Ma, Y. Luo et al., "Additional role of serum 25-hydroxyvitamin D3 levels in atherosclerosis in Chinese middleaged and elderly men," Clinical and Experimental Pharmacology and Physiology, vol. 41, no. 3, pp. 174-179, 2014.
12. P. G. Weyland, W. B. Grant, and J. Howie-Esquivel, "Does sufficient evidence exist to support a causal association between vitaminDstatus and cardiovascular disease risk? An assessment using Hill's criteria for causality," Nutrients, vol. 6, no. 9, pp. 3403-3430, 2014.
13. K. Kienreich, A. Tomaschitz, N. Verheyen et al., "VitaminDand cardiovascular disease," Nutrients, vol. 5, no. 8, pp. 3005-3021, 2013.
14. H. Khan, S. Kunutsor, O. H. Franco, and R. Chowdhury, "Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies," Proceedings of theNutrition Society, vol. 72, no. 1, pp.89-97, 2013.
15. B. A. Laway, S. K. Kotwal, andZ. A. Shah, "Patternof 25hydroxy vitamin D status in North Indian people with newly detected type 2 diabetes: a prospective case control study," Indian Journal of Endocrinology and Metabolism, vol. 18, no. 5, pp. 726-730, 2014.
16. C. V. Harinarayan, "Vitamin D and diabetes mellitus," Hormones, vol. 13, no. 2, pp. 163-181, 2014.
17. N. G. Forouhi, Z. Ye, A. P. Rickard et al., "Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies," Diabetologia, vol. 55, no. 8, pp. 2173-2182, 2012.
18. S. J. Chung, Y. A. Lee, H. Hong et al., "Inverse relationship between vitamin D status and insulin resistance and the risk of impaired fasting glucose in Korean children and adolescents: the Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2010," Public Health Nutrition, vol. 17, no. 4, pp. 795-802, 2014.
19. R. Feng, Y. Li, G. Li et al., "Lower serum 25 (OH) D concentrations in type 1 diabetes: a meta-analysis," Diabetes Research and Clinical Practice, vol. 108, no. 3, pp. e71-e75, 2015.
20. E. Serra-Planas, E. Aguilera, M. L. Granada et al., "High prevalence of vitamin D deficiency and lack of association with subclinical atherosclerosis in asymptomatic patients with Type 1 diabetes mellitus from a Mediterranean area," Acta Diabetologica, vol. 52, no. 4, pp. 773-779, 2015.
21. E. M. Shih, S. Mittelman, P. Pitukcheewanont, C. G. Azen, and R. Monzavi, "Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescentswith type 1 diabetes," Pediatric Diabetes, 2015.
22. N. Nigil Haroon, A. Anton, J. John, and M. Mittal, "Effect of vitaminDsupplementation on glycemic control in patientswith type 2 diabetes: a systematic review of interventional studies," Journal of Diabetes & Metabolic Disorders, vol. 14, no. 1, article 3, 2015.
23. J. P. Reis, E. D. Michos, E. Selvin, J. S. Pankow, and P. L. Lutsey, "Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study," American Journal of Clinical Nutrition, vol. 101, no. 6, pp. 1232-1240, 2015.
24. Y. Gao, X. Wu, Q. Fu, Y. Li, T. Yang, and W. Tang, "The relationship between serum 25-hydroxy vitamin D and insulin sensitivity and β-cell function in newly diagnosed type 2 diabetes," Journal of Diabetes Research, vol. 2015, Article ID636891, 5 pages, 2015.
25. A. Sadiya, S. M. Ahmed, M. Carlsson et al., "Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: a randomized controlled double-blinded clinical trial," Clinical Nutrition, 2015.
26. U. Kampmann, L. Mosekilde, C. Juhl et al., "Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial," Metabolism, vol. 63, no. 9, pp. 1115-1124, 2014.
27. R. Heshmat, O. Tabatabaei-Malazy, S. Abbaszadeh-Ahranjani et al., "Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial," DARU Journal of Pharmaceutical Sciences, vol. 20, no. 1, article 10, 2012.
28. M. S. Kuchay, B. A. Laway, M. I. Bashir, A. I. Wani, R. A. Misgar, and Z. A. Shah, "Effect of Vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes: a 1-year, open-label randomized study," Indian Journal of Endocrinology and Metabolism, vol. 19, no. 3, pp. 387-392, 2015.
29. L. Tripkovic, H. Lambert, K. Hart et al., "Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and metaanalysis," American Journal of Clinical Nutrition, vol. 95, no. 6, pp. 1357-1364, 2012.
30. U. Alam, A. W. S. Chan, A. Buazon et al., "Differential effects of different vitamin D replacement strategies in patients with diabetes," Journal of Diabetes and Its Complications, vol. 28, no. 1, pp. 66-70, 2014.
31. R. J. Moon, N. C. Harvey, and C. Cooper, "Endocrinology in pregnancy: influence of maternal vitamin D status on obstetric outcomes and the fetal skeleton," European Journal of Endocrinology, vol. 173, no. 2, pp. R69-R83, 2015.
32. N. C. Harvey, C. Holroyd, G. Nitani et al., "Vitamin D supplementation in pregnancy: a systematic review," Health Technology of Assessment, vol. 18, no. 45, pp. 1-190, 2014.
33. D. L. Arnold, D. A. Enquobahrie, C. Qiu et al., "Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes mellitus," Paediatric and Perinatal Epidemiology, vol. 29, no. 3, pp. 200-210, 2015.
34. J.-Y. Dong, W.-G. Zhang, J. J. Chen, Z.-L. Zhang, S.-F. Han, and L.-Q. Qin, "VitaminDintake and risk of type 1 diabetes: ametaanalysis of observational studies," Nutrients, vol. 5, no. 9, pp. 3551-3562, 2013.
35. S. Afzal, P. Brøndum-Jacobsen, S. E. Bojesen, and B. G. Nordestgaard, "Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study," The Lancet Diabetes and Endocrinology, vol. 2, no. 4, pp. 298-306, 2014.
36. N. Elkum, F. Alkayal, F. Noronha et al., "VitaminDinsufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes," PLoS ONE, vol. 9, no. 11, Article ID e113102, 2014.
37. R. J. Strawbridge, A. Deleskog, O. McLeod et al., "A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness)," Diabetologia, vol. 57, no. 6, pp. 1159-1172, 2014.
38. C. L. Wagner, S. N. Taylor, A. Dawodu, D. D. Johnson, andB.W. Hollis, "Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus," Nutrients, vol. 4, no. 3, pp. 208-230, 2012.
39. J. A. Tamblyn, M. Hewison, C. L. Wagner, J. N. Bulmer, and M. D. Kilby, "Immunological role of vitaminDat the maternal-fetal interface," Journal of Endocrinology, vol. 224, no. 3, pp. R107- R121, 2015.
40. C. E. Hayes, S. L. Hubler, J. R. Moore, L. E. Barta, C. E. Praska, and F. E. Nashold, "Vitamin D actions on CD4+ T cells in autoimmune disease," Frontiers in Immunology, vol. 6, article 100, 2015.
41. T. L. Van Belle, A. Vanherwegen, D. Feyaerts et al., "1,25-dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patients," PLoS ONE, vol. 9, no. 10, Article IDe109194, 2014.
42. C. Ning, L. Liu, G. Lv et al., "Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats," Lipids in Health and Disease, vol. 14, article 31, 2015.
43. L. Mao, F. Ji, Y. Liu, W. Zhang, and X. Ma, "Calcitriol plays a protective role in diabetic nephropathy through antiinflammatory effects," International Journal of Clinical and Experimental Medicine, vol. 7, no. 12, pp. 5437-5444, 2014.
44. C.-K. Cheon, H.-K. Nam, K.-H. Lee, S. Y. Kim, J. S. Song, and C. Kim, "Vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in a Korean population," Pediatrics International, 2015.
45. Y. Morán-Auth, M. Penna-Martinez, and K. Badenhoop, "VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients," The Journal of Steroid Biochemistry and Molecular Biology, vol. 148, pp. 184-186, 2015.
46. Z. Liu, L. Liu, X. Chen, W. He, and X. Yu, "Associations study of vitamin D receptor gene polymorphisms with diabetic microvascular complications: a meta-analysis," Gene, vol. 546, no. 1, pp. 6-10, 2014.
47. J. De Azevêdo Silva, R. L. Guimarães, L. A. C. Brandão et al., "VitaminDreceptor (VDR) gene polymorphisms and age onset in type 1 diabetes mellitus," Autoimmunity, vol. 46, no. 6, pp. 382-387, 2013.
48. K. Tizaoui, W. Kaabachi, A. Hamzaoui, and K. Hamzaoui, "Contribution of VDR polymorphisms to type 1 diabetes susceptibility: systematic review of case-control studies and metaanalysis," The Journal of Steroid Biochemistry and Molecular Biology, vol. 143, pp. 240-249, 2014.
49. M. M. Kamel, S. A. Fouad, O. Salaheldin, A. E.-R. A. A. El-Razek, andA. I.A. El-Fatah, "Impact of vitaminDreceptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus," International Journal of Clinical and ExperimentalMedicine, vol. 7, no. 12, pp. 5505-5510, 2014.
50. X. Zhong, Y. Du, Y. Lei, N. Liu, Y. Guo, and T. Pan, "Effects of vitamin D receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in Han Chinese type 2 diabetes patients," Gene, vol. 566, no. 2, pp. 212-216, 2015.
51. B. Frederiksen, E. Liu, J. Romanos et al., "Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)," Journal of Steroid Biochemistry and Molecular Biology, vol. 133, no. 1, pp. 51-57, 2013.
52. X. Wu, R. C. Davis, T. S. McMillen et al., "Geneticmodulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation," Physiological Reports, vol. 2, no. 11, Article IDe12208, 2014.
53. D. Dutta, S. Choudhuri, S. A. Mondal, S. Mukherjee, and S. Chowdhury, "Urinary albumin: creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: role of associated insulin resistance, inflammatory cytokines and low vitamin D," Journal of Diabetes, vol. 6, no. 4, pp. 316-322, 2014.
54. A. M. H. Mackawy and M. E. H. Badawi, "Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance andmetabolic syndrome components in type 2 diabetic Egyptian patients," Meta Gene, vol. 2, pp. 540-556, 2014.
55. G. Zoppini, A. Galletti, G. Targher et al., "Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes," BMJ Open Diabetes Research & Care, vol. 3, no. 1, Article ID e000058, 2015.
56. R. M. Sánchez-Hernández, C. García-Cantón, D. L. Lorenzo et al., "The specific relationship between vitamin D deficiency and diabetic nephropathy among patients with advanced chronic kidney disease: a cross-sectional study in Gran Canaria, Spain," Clinical Nephrology, vol. 83, no. 04, pp. 218-224, 2015.
57. N. Shimo, T. Yasuda, H. Kaneto et al., "Vitamin D deficiency is significantly associatedwith retinopathy in young Japanese type 1 diabetic patients," Diabetes Research and Clinical Practice, vol. 106, no. 2, pp. e41-e43, 2014.
58. S. Bonakdaran andN. Shoeibi, "Is there any correlation between vitamin D insufficiency and diabetic retinopathy?" International Journal of Ophthalmology, vol. 8, no. 2, pp. 326-331, 2015.
59. X.-L. Zhang, Y.-F. Guo, Z.-X. Song, and M. Zhou, "Vitamin D prevents podocyte injury via regulation of macrophage M1/M2 phenotype in diabetic nephropathy rats," Endocrinology, vol. 155, no. 12, pp. 4939-4950, 2014.
60. Y. Tian, G. Lv, Y. Yang et al., "Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats," International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 3028-3037, 2014.
61. S. Goto, H. Fujii, K. Kono et al., "22-oxacalcitriol attenuates bone loss in nonobese type 2 diabetes," Bone, vol. 74, pp. 153-159, 2015.
62. R.-H. Chen, X.-H. Zhao, Z. Gu et al., "Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults," Endocrine, vol. 45, no. 2, pp. 319-324, 2014.
63. G. Muscogiuri, V. Nuzzo, A. Gatti et al., "Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?" Endocrine, pp. 1-6, 2015.
64. A. E. Riek, J. Oh, I. Darwech, C. E. Moynihan, R. R. Bruchas, and C. Bernal-Mizrachi, "25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes," Journal of Steroid Biochemistry and Molecular Biology, vol. 144, pp. 172-179, 2014.
65. W. Zhou and S. D. Ye, "Relationship between serum 25-hydroxyvitamin D and lower extremity arterial disease in type 2 diabetes mellitus patients and the analysis of the intervention of vitamin D," Journal of Diabetes Research, vol. 2015, Article ID 815949, 6 pages, 2015.
66. B. Schöttker and H. Brenner, "Vitamin D as a resilience factor, helpful for survival of potentially fatal conditions: a hypothesis emerging fromrecent findings of the ESTHER cohort study and the CHANCES consortium," Nutrients, vol. 7, no. 5, pp. 3264-3278, 2015.
67. R. Chowdhury, S. Kunutsor, A. Vitezova et al., "Vitamin D and risk of cause specific death: systematic reviewandmeta-analysis of observational cohort and randomised intervention studies," The BMJ, vol. 348, article g1903, 2014.
68. S. Afzal, P. Brondum-Jacobsen, S. E. Bojesen, and B. G. Nordestgaard, "Genetically low vitamin D concentrations and increasedmortality:mendelian randomisation analysis in three large cohorts," British Medical Journal, vol. 349, Article ID g6330, 2014.
69. H. M. Lee, M. Liu, K. Lee, Y. Luo, and N. D. Wong, "Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality?" Clinical Cardiology, vol. 37, no. 8, pp. 473-478, 2014.
70. T. Skaaby, L. L. N. Husemoen, B. H. Thuesen et al., "Vitamin D status and chronic obstructive pulmonary disease: a prospective general population study," PloS ONE, vol. 9, no. 3, Article ID e90654, 2014.
71. V. Andre's, "Vitamin D puts the brakes on angiotensin IIinduced oxidative stress and vascular smooth muscle cell senescence," Atherosclerosis, vol. 236, no. 2, pp. 444-447, 2014.
72. J. Oh, A. Riek, I. Darwech et al., "Deletion of macrophage vitamin d receptor promotes insulin resistance and monocyte cholesterol transport to accelerate atherosclerosis in mice," Cell Reports, vol. 10, no. 11, pp. 1872-1886, 2015.
73. I. Mozos and O. Marginean, "Links between vitamin D deficiency and cardiovascular diseases," BioMed Research International, vol. 2015, Article ID 109275, 12 pages, 2015.
74. A. R. Menezes, M. C. Lamb, C. J. Lavie, and J. J. DiNicolantonio, "VitaminDand atherosclerosis," CurrentOpinion in Cardiology, vol. 29, no. 6, pp. 571-577, 2014.
75. T. Skaaby, L. L. N. Husemoen, T. Martinussen et al., "Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a mendelian randomization approach," PLoS ONE, vol. 8, no. 2, Article ID e57647, 2013.
76. T. Skaaby, L. L. N. Husemoen, C. Pisinger et al., "Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population," Cardiology (Switzerland), vol. 123, no. 1, pp. 62-70, 2012.
77. A. Lertratanakul, P. Wu, A. Dyer et al., "25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort," Arthritis Care & Research, vol. 66, no. 8, pp. 1167-1176, 2014.
78. A. Vitezova, M. C. Zillikens, T. T. VanHerpt et al., "Vitamin D status and metabolic syndrome in the elderly: the Rotterdam study," European Journal of Endocrinology, vol. 172, no. 3, pp. 327-335, 2015.
79. S. Lai, B. Coppola, M. Dimko et al., "Vitamin D deficiency, insulin resistance, and ventricular hypertrophy in the early stages of chronic kidney disease," Renal Failure, vol. 36, no. 1, pp. 58-64, 2014.
80. L. Perna, B. Schöttker, B. Holleczek, and H. Brenner, "Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements," Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 12, pp. 4908-4915, 2013.
81. P. F. Schnatz, M. Nudy, X. Jiang, J. E. Demko, and S. E. Appt, "Vitamin D deficiency and cardiovascular disease in postmenopausal women: contributions from human and nonhuman primate studies," Menopause, vol. 22, no. 5, pp. 554-563, 2015.
82. A. Vitezova, N. S. Cartolano, J. Heeringa et al., "Vitamin D and the risk of atrial fibrillation - the rotterdam study," PLoS ONE, vol. 10, no. 5, Article ID e0125161, 2015.
83. C. McGreevy, M. Barry, C. Davenport et al., "The effect of vitamin D supplementation on arterial stiffness in an elderly community-based population," Journal of the American Society of Hypertension, vol. 9, no. 3, pp. 176-183, 2015.
84. D. Martins, Y. Meng, N. Tareen et al., "The effect of short term vitamin d supplementation on the inflammatory and oxidative mediators of arterial stiffness," Health, vol. 6, no. 12, pp. 1503-1511, 2014.
85. O.-H. Ryu, W. Chung, S. Lee, K.-S. Hong, M.-G. Choi, and H. J. Yoo, "The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes," Korean Journal of InternalMedicine, vol. 29, no. 5, pp. 620-629, 2014.
86. T. Skaaby, L. L. N. Husemoen, C. Pisinger et al., "Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study," Endocrine, vol. 43, no. 3, pp. 618-625, 2013.
87. A. Gupta, S. Prabhakar, M. Modi, S. K. Bhadada, V. Lal, and D. Khurana, "Vitamin D status and risk of ischemic stroke in North Indian patients," Indian Journal of Endocrinology and Metabolism, vol. 18, no. 5, pp. 721-725, 2014.
88. A. Roy, R. Lakshmy, M. Tarik, N. Tandon, K. S. Reddy, and D. Prabhakaran, "Independent association of severe vitamin D deficiency as a risk of acute myocardial infarction in Indians," Indian Heart Journal, vol. 67, no. 1, pp. 27-32, 2015.
89. P. L. Lutsey, E.D. Michos, J. R. Misialek et al., "Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: the ARIC (Atherosclerosis Risk in Communities) study," Heart Failure, vol. 3, no. 5, pp. 347-356, 2015.
90. K. S. Vimaleswaran, A. Cavadino, D. J. Berry et al., "Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study," The Lancet Diabetes & Endocrinology, vol. 2, no. 9, pp. 719-729, 2014.
91. S. Pilz, M. Gaksch, K. Kienreich et al., "Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial," Hypertension, vol. 65, no. 6, pp. 1195-1201, 2015.
92. D. Rendina, R. Ippolito, L. D'Elia et al., "Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD): study design, clinical procedures and treatment protocol," High Blood Pressure & Cardiovascular Prevention, vol. 22, no. 2, pp. 135-142, 2015.
93. P. F. Schnatz and J. E. Manson, "Vitamin D and cardiovascular disease: an appraisal of the evidence," Clinical Chemistry, vol. 60, no. 4, pp. 600-609, 2014.
94. S. K. Kunutsor, S. Burgess, P. B. Munroe, and H. Khan, "Vitamin D and high blood pressure: causal association or epiphenomenon?" European Journal of Epidemiology, vol. 29, no. 1, pp. 1-14, 2014.
95. M. Sunbul, M. Bozbay, C. Mammadov et al., "Effect of vitamin D deficiency and supplementation on myocardial deformation parameters and epicardial fat thickness in patients free of cardiovascular risk,"The International Journal of Cardiovascular Imaging, vol. 31, no. 4, pp. 765-772, 2015.
96. S. Bonakdaran, A. F. Nejad, V. Abdol-Reza, A. Hatefi, and M. Shakeri, "Impact of oral 1,25-dihydroxy vitamin D (calcitriol) replacement therapy on coronary artery risk factors in type 2 diabetic patients," Endocrine, Metabolic & Immune Disorders Drug Targets, vol. 13, no. 4, pp. 295-300, 2013.
97. K. Tomaino, K. M. Romero, C. L. Robinson et al., "Association between serum 25-hydroxy vitaminDlevels and blood pressure among adolescents in two resource-limited settings in Peru," American Journal of Hypertension, vol. 28, no. 8, pp. 1017-1023, 2015.
98. H. Mozaffari-Khosravi, S. Loloei, M.-R. Mirjalili, and K. Barzegar, "The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: a randomized, double-blind, placebo-controlled trial," Blood Pressure Monitoring, vol. 20, no. 2, pp. 83-91, 2015.
99. K. M. Gurses, L. Tokgozoglu, M. U. Yalcin et al., "Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement," Atherosclerosis, vol. 237, no. 2, pp. 784-789, 2014.
100. A. B. Robinson, V. Tangpricha, E. Yow, R. Gurion, L. E. Schanberg, and G. A. McComsey, "Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy," Lupus Science &Medicine, vol. 1, no. 1, Article ID e000037, 2014.
101. S. Satilmis, O. Celik, I. Biyik et al., "Association between serumvitaminDlevels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population," Bosnian Journal of Basic Medical Sciences, vol. 15, no. 1, pp. 67-72, 2015.
102. A. Alyami, M. J. Soares, J. L. Sherriff, and J. C. Mamo, "Vitamin D & endothelial function," The Indian Journal of Medical Research, vol. 140, no. 4, pp. 483-490, 2014.
103. J. S. Ho, J. J. Cannaday, C. E. Barlow, D. B. Reinhardt, W. A. Wade, and J. R. Ellis, "Low 25-OH vitamin D levels are not associated with coronary artery calcium or obstructive stenoses," Coronary Artery Disease, vol. 26, no. 6, pp. 521-525, 2015.
104. J. Y. Liew, S. R. Sasha, P. J. Ngu et al., "Circulating vitamin D levels are associated with the presence and severity of coronary artery disease but not peripheral arterial disease in patients undergoing coronary angiography," Nutrition, Metabolism and Cardiovascular Diseases, vol. 25, no. 3, pp. 274-279, 2015.
105. R. Malik, E. C. Aneni, L. Roberson et al., "Measuring coronary artery calcification: is serumvitamin D relevant?" Atherosclerosis, vol. 237, no. 2, pp. 734-738, 2014.
106. K. Winckler, L. Tarnow, L. L. Christensen et al., "Vitamin D, carotid intima-media thickness and bone structure in patients with type 2 diabetes," Endocrine Connections, vol. 4, no. 2, pp. 128-135, 2015.
107. J.-Y. Jung, B.-R. Koh, C.-B. Bae, H.-A. Kim, and C.-H. Suh, "Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus," Lupus, vol. 23, no. 14, pp. 1517-1522, 2014.
108. A. N. Kiani, H. Fang, L. S. Magder, and M. Petri, "Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity Creactive protein in systemic lupus erythematosus," Rheumatology, vol. 52, no. 11, Article ID ket271, pp. 2071-2076, 2013.
109. J. Portilla, Ó. Moreno-Pérez, C. Serna-Candel et al., "Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males livingwithHIV," Journal of the InternationalAIDS Society, vol. 17, Article ID18945, 2014.
110. H. Mangge, S. Zelzer, A. Meinitzer et al., "25OH-vitamin D3 levels in obesity and metabolic syndrome - unaltered in young and not correlated to carotid IMT in all ages," Current Pharmaceutical Design, vol. 21, no. 17, pp. 2243-2249, 2015.
111. M. D. Walker, E. Cong, A. Kepley et al., "Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism," Journal of Clinical Endocrinology andMetabolism, vol. 99, no. 2, pp. 671-680, 2014.
112. V. Carnevale, R. Minonne, A. De Matthaeis et al., "Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department," Endocrine, vol. 47, no. 3, pp. 833-838, 2014.
113. R.-H. Chen, X.-Z. Jiang, Q. Jiang et al., "Correlations between serum levels of 25-hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai," Annales d'Endocrinologie, vol. 75, no. 4, pp. 206-212, 2014.
114. J. Orgaz-Molina, C. Magro-Checa, J. L. Rosales-Alexander et al., "Vitamin D insufficiency is associated with higher carotid intima-media thickness in psoriatic patients," European Journal of Dermatology, vol. 24, no. 1, pp. 53-62, 2014.
115. Y. Hao, X. Ma, Y. Luo et al., "Inverse association of serum vitamin D in relation to carotid intima-media thickness in Chinese postmenopausal women," PLoS ONE, vol. 10, no. 3, Article ID e0122803, 2015.
116. M. Juonala, A. Voipio, K. Pahkala et al., "Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study," The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 4, pp. 1469-1476, 2015.
117. S. C. Van Dijk, E. Sohl, C. Oudshoorn et al., "Non-linear associations between serum 25-OH vitamin D and indices of arterial stiffness and arteriosclerosis in an older population," Age and Ageing, vol. 44, no. 1, pp. 136-142, 2015.
118. G. Y. Kalkan, M. Gür, N. Y. Koyunsever et al., "Serum 25-hydroxyvitamin D level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease," Journal of Clinical Laboratory Analysis, vol. 29, no. 4, pp. 305-311, 2015.
119. K. Gholami, A. H. Talasaz, T. Entezari-Maleki et al., "The effect of high-dose vitamin D3 on soluble P-selectin and hs-CRP level in patients with venous thromboembolism: a randomized clinical trial," Clinical and AppliedThrombosis/Hemostasis, 2015.
120. T. Entezari-Maleki, A. H. Talasaz, M. Salarifar et al., "Plasma vitamin D status and its correlation with risk factors of thrombosis, P-selectin and hs-CRP level in patients with venous thromboembolism; the first study of iranian population," Iranian Journal of Pharmaceutical Research, vol. 13, no. 1, pp. 319-327, 2014.
121. A. R. Folsom, N. S. Roetker, W. D. Rosamond et al., "Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study," Journal of Thrombosis and Haemostasis, vol. 12, no. 9, pp. 1455-1460, 2014.
122. P. Ameri, M. Canepa, P. Fabbi et al., "Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness," Atherosclerosis, vol. 236, no. 2, pp. 418-425, 2014.
123. H. Y. Park, J. H. Kim, S. Bae, Y. Y. Choi, J. Y. Park, and Y.-C. Hong, "Interaction effect of serum 25-hydroxyvitamin D levels and CYP1A1, CYP1B1 polymorphisms on blood pressure in an elderly population," Journal of Hypertension, vol. 33, no. 1, pp. 69-76, 2015.
124. M. A. Abu El Maaty, S. I. Hassanein, H. M. Sleem, and M. Z. Gad, "Effect of polymorphisms in the NADSYN1/DHCR7 locus (rs12785878 and rs1790349) on plasma 25-hydroxyvitamin D levels and coronary artery disease incidence," Journal of Nutrigenetics and Nutrigenomics, vol. 6, no. 6, pp. 327-335, 2014.